UniProt ID | RMI1_HUMAN | |
---|---|---|
UniProt AC | Q9H9A7 | |
Protein Name | RecQ-mediated genome instability protein 1 | |
Gene Name | RMI1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 625 | |
Subcellular Localization | Nucleus . Forms foci in response to DNA damage. | |
Protein Description | Essential component of the RMI complex, a complex that plays an important role in the processing of homologous recombination intermediates to limit DNA crossover formation in cells. Promotes TOP3A binding to double Holliday junctions (DHJ) and hence stimulates TOP3A-mediated dissolution. Required for BLM phosphorylation during mitosis. Within the BLM complex, required for BLM and TOP3A stability.. | |
Protein Sequence | MNVTSIALRAETWLLAAWHVKVPPMWLEACINWIQEENNNVNLSQAQMNKQVFEQWLLTDLRDLEHPLLPDGILEIPKGELNGFYALQINSLVDVSQPAYSQIQKLRGKNTTNDLVTAEAQVTPKPWEAKPSRMLMLQLTDGIVQIQGMEYQPIPILHSDLPPGTKILIYGNISFRLGVLLLKPENVKVLGGEVDALLEEYAQEKVLARLIGEPDLVVSVIPNNSNENIPRVTDVLDPALGPSDEELLASLDENDELTANNDTSSERCFTTGSSSNTIPTRQSSFEPEFVISPRPKEEPSNLSIHVMDGELDDFSLEEALLLEETVQKEQMETKELQPLTFNRNADRSIERFSHNPNTTNNFSLTCKNGNNNWSEKNVSEQMTNEDKSFGCPSVRDQNRSIFSVHCNVPLAHDFTNKEKNLETDNKIKQTSSSDSHSLNNKILNREVVNYVQKRNSQISNENDCNLQSCSLRSSENSINLSIAMDLYSPPFVYLSVLMASKPKEVTTVKVKAFIVTLTGNLSSSGGIWSITAKVSDGTAYLDVDFVDEILTSLIGFSVPEMKQSKKDPLQYQKFLEGLQKCQRDLIDLCCLMTISFNPSLSKAMVLALQDVNMEHLENLKKRLNK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MNVTSIAL -------CCHHHHHH | 9.09 | 22814378 | |
4 | Phosphorylation | ----MNVTSIALRAE ----CCHHHHHHHHH | 14.93 | 24719451 | |
109 | Ubiquitination | QIQKLRGKNTTNDLV HHHHHCCCCCCCCCE | 44.69 | 33845483 | |
111 | Phosphorylation | QKLRGKNTTNDLVTA HHHCCCCCCCCCEEE | 30.38 | - | |
112 | Phosphorylation | KLRGKNTTNDLVTAE HHCCCCCCCCCEEEE | 35.81 | - | |
123 | Phosphorylation | VTAEAQVTPKPWEAK EEEEEECCCCCCCCC | 17.32 | 25159151 | |
125 | Ubiquitination | AEAQVTPKPWEAKPS EEEECCCCCCCCCCC | 54.09 | 29967540 | |
130 | Ubiquitination | TPKPWEAKPSRMLML CCCCCCCCCCCEEEE | 31.82 | - | |
132 | Phosphorylation | KPWEAKPSRMLMLQL CCCCCCCCCEEEEEE | 29.61 | - | |
174 | Phosphorylation | ILIYGNISFRLGVLL EEEECEEEEEEEEEE | 14.33 | 24719451 | |
183 | Ubiquitination | RLGVLLLKPENVKVL EEEEEEECHHHEEEC | 50.70 | - | |
205 | Ubiquitination | LEEYAQEKVLARLIG HHHHHHHHHHHHHHC | 30.39 | 21906983 | |
219 | Phosphorylation | GEPDLVVSVIPNNSN CCCCEEEEEECCCCC | 13.57 | 29255136 | |
225 | Phosphorylation | VSVIPNNSNENIPRV EEEECCCCCCCCCCC | 52.76 | 29255136 | |
233 | Phosphorylation | NENIPRVTDVLDPAL CCCCCCCEECCCCCC | 22.97 | 26074081 | |
243 | Phosphorylation | LDPALGPSDEELLAS CCCCCCCCHHHHHHC | 56.72 | 30278072 | |
250 | Phosphorylation | SDEELLASLDENDEL CHHHHHHCCCCCCCC | 36.00 | 28102081 | |
258 | Phosphorylation | LDENDELTANNDTSS CCCCCCCCCCCCCCC | 25.87 | 28634120 | |
270 | Phosphorylation | TSSERCFTTGSSSNT CCCCCEECCCCCCCC | 33.60 | 26074081 | |
271 | Phosphorylation | SSERCFTTGSSSNTI CCCCEECCCCCCCCC | 18.14 | 26074081 | |
273 | Phosphorylation | ERCFTTGSSSNTIPT CCEECCCCCCCCCCC | 28.62 | 25159151 | |
274 | Phosphorylation | RCFTTGSSSNTIPTR CEECCCCCCCCCCCC | 29.02 | 25159151 | |
275 | Phosphorylation | CFTTGSSSNTIPTRQ EECCCCCCCCCCCCC | 39.42 | 25159151 | |
277 | Phosphorylation | TTGSSSNTIPTRQSS CCCCCCCCCCCCCCC | 30.22 | 26074081 | |
280 | Phosphorylation | SSSNTIPTRQSSFEP CCCCCCCCCCCCCCC | 37.17 | 26074081 | |
283 | Phosphorylation | NTIPTRQSSFEPEFV CCCCCCCCCCCCCEE | 33.43 | 30266825 | |
284 | Phosphorylation | TIPTRQSSFEPEFVI CCCCCCCCCCCCEEE | 25.87 | 30266825 | |
292 | Phosphorylation | FEPEFVISPRPKEEP CCCCEEECCCCCCCC | 15.00 | 30266825 | |
334 | Sumoylation | QKEQMETKELQPLTF HHHHHCCCCCCCCCC | 43.02 | - | |
334 | Sumoylation | QKEQMETKELQPLTF HHHHHCCCCCCCCCC | 43.02 | 28112733 | |
334 | Ubiquitination | QKEQMETKELQPLTF HHHHHCCCCCCCCCC | 43.02 | 29967540 | |
348 | Phosphorylation | FNRNADRSIERFSHN CCCCCCCCEECCCCC | 29.37 | 28102081 | |
359 | Phosphorylation | FSHNPNTTNNFSLTC CCCCCCCCCCEEEEE | 34.50 | 25159151 | |
363 | Phosphorylation | PNTTNNFSLTCKNGN CCCCCCEEEEEECCC | 25.54 | 25159151 | |
374 | Phosphorylation | KNGNNNWSEKNVSEQ ECCCCCCCCCCHHHH | 40.59 | 21082442 | |
376 | Ubiquitination | GNNNWSEKNVSEQMT CCCCCCCCCHHHHCC | 58.07 | 29967540 | |
383 | Phosphorylation | KNVSEQMTNEDKSFG CCHHHHCCCCCHHCC | 34.84 | 29214152 | |
387 | Ubiquitination | EQMTNEDKSFGCPSV HHCCCCCHHCCCCCH | 41.32 | 29967540 | |
387 | Sumoylation | EQMTNEDKSFGCPSV HHCCCCCHHCCCCCH | 41.32 | 28112733 | |
388 | Phosphorylation | QMTNEDKSFGCPSVR HCCCCCHHCCCCCHH | 38.91 | 25159151 | |
393 | Phosphorylation | DKSFGCPSVRDQNRS CHHCCCCCHHCCCCC | 33.58 | 26270265 | |
400 | Phosphorylation | SVRDQNRSIFSVHCN CHHCCCCCEEEEECC | 35.22 | 30576142 | |
403 | Phosphorylation | DQNRSIFSVHCNVPL CCCCCEEEEECCCCC | 14.85 | 28555341 | |
415 | Phosphorylation | VPLAHDFTNKEKNLE CCCCCCCCCCCCCCC | 51.98 | - | |
426 | Sumoylation | KNLETDNKIKQTSSS CCCCCCCCCCCCCCC | 54.83 | 28112733 | |
426 | Ubiquitination | KNLETDNKIKQTSSS CCCCCCCCCCCCCCC | 54.83 | 27667366 | |
428 | Ubiquitination | LETDNKIKQTSSSDS CCCCCCCCCCCCCCC | 49.48 | 29967540 | |
433 | Phosphorylation | KIKQTSSSDSHSLNN CCCCCCCCCCCCCHH | 42.79 | 25599653 | |
435 | Phosphorylation | KQTSSSDSHSLNNKI CCCCCCCCCCCHHHH | 19.54 | 25599653 | |
441 | Ubiquitination | DSHSLNNKILNREVV CCCCCHHHHHCHHHH | 47.71 | 27667366 | |
450 | Phosphorylation | LNREVVNYVQKRNSQ HCHHHHHHHHHHCCC | 7.83 | 27642862 | |
453 | Acetylation | EVVNYVQKRNSQISN HHHHHHHHHCCCCCC | 43.43 | 25953088 | |
453 | Ubiquitination | EVVNYVQKRNSQISN HHHHHHHHHCCCCCC | 43.43 | 21906983 | |
456 | Phosphorylation | NYVQKRNSQISNEND HHHHHHCCCCCCCCC | 32.68 | 30576142 | |
459 | Phosphorylation | QKRNSQISNENDCNL HHHCCCCCCCCCCCC | 30.38 | 30576142 | |
473 | Phosphorylation | LQSCSLRSSENSINL CCHHCCCCCCCCEEE | 47.50 | 30576142 | |
474 | Phosphorylation | QSCSLRSSENSINLS CHHCCCCCCCCEEEH | 34.07 | 30576142 | |
500 | Phosphorylation | YLSVLMASKPKEVTT EEEHHHCCCCCCCEE | 35.21 | 30576142 | |
516 | Phosphorylation | KVKAFIVTLTGNLSS EEEEEEEEECCCCCC | 17.49 | 21406692 | |
518 | Phosphorylation | KAFIVTLTGNLSSSG EEEEEEECCCCCCCC | 18.04 | 21406692 | |
522 | Phosphorylation | VTLTGNLSSSGGIWS EEECCCCCCCCCEEE | 26.85 | 21406692 | |
523 | Phosphorylation | TLTGNLSSSGGIWSI EECCCCCCCCCEEEE | 35.85 | 21406692 | |
524 | Phosphorylation | LTGNLSSSGGIWSIT ECCCCCCCCCEEEEE | 37.35 | 21406692 | |
529 | Phosphorylation | SSSGGIWSITAKVSD CCCCCEEEEEEEECC | 14.24 | 21406692 | |
531 | Phosphorylation | SGGIWSITAKVSDGT CCCEEEEEEEECCCE | 18.21 | 21406692 | |
535 | Phosphorylation | WSITAKVSDGTAYLD EEEEEEECCCEEEEC | 29.62 | 22210691 | |
538 | Phosphorylation | TAKVSDGTAYLDVDF EEEECCCEEEECCHH | 19.67 | 21406692 | |
540 | Phosphorylation | KVSDGTAYLDVDFVD EECCCEEEECCHHHH | 11.85 | 21406692 | |
551 | Phosphorylation | DFVDEILTSLIGFSV HHHHHHHHHHHCCCH | 27.44 | 21406692 | |
552 | Phosphorylation | FVDEILTSLIGFSVP HHHHHHHHHHCCCHH | 17.97 | 21406692 | |
557 | Phosphorylation | LTSLIGFSVPEMKQS HHHHHCCCHHHHHHC | 31.39 | 22210691 | |
566 | Ubiquitination | PEMKQSKKDPLQYQK HHHHHCCCCHHHHHH | 70.58 | 27667366 | |
573 | Ubiquitination | KDPLQYQKFLEGLQK CCHHHHHHHHHHHHH | 47.16 | 29967540 | |
580 | Ubiquitination | KFLEGLQKCQRDLID HHHHHHHHHHHHHHH | 37.06 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RMI1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RMI1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RMI1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
FANCM_HUMAN | FANCM | physical | 20064461 | |
BLM_HUMAN | BLM | physical | 20064461 | |
RMI2_HUMAN | RMI2 | physical | 20064461 | |
TOP3A_HUMAN | TOP3A | physical | 20064461 | |
TOP3A_HUMAN | TOP3A | physical | 26186194 | |
DCA15_HUMAN | DCAF15 | physical | 26186194 | |
DCA15_HUMAN | DCAF15 | physical | 28514442 | |
TOP3A_HUMAN | TOP3A | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292, AND MASSSPECTROMETRY. |